Sunday, October 25, 2026
Biotech

Doctors Back New Moderna and Merck Cancer Vaccine

Cancer doctors praise new vaccine data from Moderna and Merck despite a cool reaction from Wall Street.

Skin cancer patients have new reason for hope today. Doctors see a big leap forward in fighting deadly melanoma.

Moderna and Merck teamed up to test a new cancer shot. Six top skin cancer doctors reviewed the trial results. They say the medicine helps patients stay cancer-free after surgery.

Wall Street traders wanted bigger numbers. Stocks slipped after the news broke. Medical experts disagree with the market doubt. They call the treatment a major step forward for medicine.

This shot teaches the body to hunt cancer cells. It gives families a stronger path to recovery. Medical progress moves forward even when stock prices swing.

Source: CNBC

#Biotech#Moderna#Merck#Cancer Research#Stock Market

More from Biotech